Clene (NASDAQ: CLNN) Announces Participation at Two Upcoming Investor Conferences
StreetIQ
Wednesday, October 9, 2024 at 4:05pm UTC
Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a
Skip to content
Close menu
STREET
IQ
Top Stories
Top CEOs
Research
Press Releases
About Us